Valeda + EyePower Home based PBM for Dry AMD
Growing evidence from research and clinical trials are showing Red light therapy is useful for Age related macular degeneration, Diabetic retinopathy and other eye diseases. While currently the Valeda System is the one licensed PhotoBioModulation therapy for the eyes, not everyone can either afford of adhere to the logistics of 9 treatments over a month at a local centre. The need for home based therapy is growing. It also raises the question of maintenance treatment between the main Valeda treatments.
The Valeda Light Delivery System, is a clinic based treatment undertaken by eye professionals supervision. It is photobiomodulation therapy (PBMT) for eye conditions like age-related macular degeneration (AMD), typically delivers energy at an output of approximately 25 mW/cm². Valeda aims to deliver light energy in the red to near-infrared spectrum, specifically at three wavelengths of 590 nm, 670 nm, and 850 nm. Valeda system is CE marked and applied for FDA (Food and Drug Administration) approval which is expected in 2024 for treatment of intermediate Age related macular degeneration.
What is the EyePower Red Device?
The EyePower Red Device is a home based device therapeutic tool designed specifically to deliver one wavelength 670nm wavelength red light to the eyes. It delivers a lower light level at 8 mW/cm². This type of light therapy is used to support and improve eye health by stimulating cellular processes within the retina and other eye tissues and considered a wellness therapy.
